{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:50:23Z","timestamp":1793731823187,"version":"4.6.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04108-y","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:16:20Z","timestamp":1743725780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The efficacy of topical cetirizine using microneedling in androgenetic alopecia male patients"],"prefix":"10.1007","volume":"317","author":[{"given":"Yasser Mostafa","family":"Gohary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma Mohamed Mohamed","family":"Elkastawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2990-5981","authenticated-orcid":false,"given":"Hasnaa","family":"Osama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Elsayed Ahmed","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"4108_CR1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.17219\/acem\/157990","volume":"32","author":"NN Nobari","year":"2023","unstructured":"Nobari NN, Roohaninasab M, Sadeghzadeh-Bazargan A, Goodarzi A, Behrangi E, Nikkhah F, Ghassemi M (2023) A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia. Adv Clin Exp Med 32:813\u2013823","journal-title":"Adv Clin Exp Med"},{"issue":"6","key":"4108_CR2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/14659891.2020.1760369","volume":"25","author":"CL Broman","year":"2020","unstructured":"Broman CL, Wright MK, Choi SH, Wang Y (2020) Heavy drug use in young adulthood. J Subst Use 25(6):626\u2013631","journal-title":"J Subst Use"},{"issue":"6","key":"4108_CR3","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1365-2133.2003.05565.x","volume":"149","author":"G Severi","year":"2003","unstructured":"Severi G, Sinclair R, Hopper JL, English DR, McCredie MRE, Boyle P, Giles GG (2003) Androgenetic alopecia in men aged 40\u201369 years: prevalence and risk factors. Br J Dermatol 149(6):1207\u20131213","journal-title":"Br J Dermatol"},{"issue":"2","key":"4108_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/cbin.11723","volume":"46","author":"Y He","year":"2022","unstructured":"He Y, Liu X, Qu Q, Chen J, Fan Z, Zhu D, Hu Z (2022) Overexpression of miR-122 promotes apoptosis of dermal papilla cells by directly targeting IGF1R in androgenetic alopecia. Cell Biol Int 46(2):185\u2013191","journal-title":"Cell Biol Int"},{"issue":"4","key":"4108_CR5","first-page":"457","volume":"17","author":"SW Lee","year":"2018","unstructured":"Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA (2018) A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. J Drugs Dermatology: JDD 17(4):457","journal-title":"J Drugs Dermatology: JDD"},{"key":"4108_CR6","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s40265-016-0629-5","volume":"76","author":"Y Kelly","year":"2016","unstructured":"Kelly Y, Blanco A, Tosti A (2016) Androgenetic alopecia: an update of treatment options. Drugs 76:1349\u20131364","journal-title":"Drugs"},{"issue":"8\u20139","key":"4108_CR7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0531-5565(02)00093-1","volume":"37","author":"RM Tr\u00fceb","year":"2002","unstructured":"Tr\u00fceb RM (2002) Molecular mechanisms of androgenetic alopecia. Exp Gerontol 37(8\u20139):981\u2013990","journal-title":"Exp Gerontol"},{"issue":"4","key":"4108_CR8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/exd.12348","volume":"23","author":"A Nieves","year":"2014","unstructured":"Nieves A, Garza LA (2014) Does prostaglandin D2 hold the cure to male pattern baldness? Exp Dermatol 23(4):224\u2013227","journal-title":"Exp Dermatol"},{"issue":"1","key":"4108_CR9","first-page":"1","volume":"23","author":"I D\u00e1vila","year":"2013","unstructured":"D\u00e1vila I, Del Cuvillo A, Mullol J, J\u00e1uregui I, Bartra J, Ferrer M, Valero A (2013) Use of second generation H. J Investig Allergol Clin Immunol 23(1):1\u201316","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"4108_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/09546634.2017.1341610","volume":"29","author":"A Rossi","year":"2018","unstructured":"Rossi A, Campo D, Fortuna M et al (2018) A preliminary study on topical Cetirizine in the therapeutic management of androgenetic alopecia. J Dermatological Treat 29(2):149\u2013151","journal-title":"J Dermatological Treat"},{"key":"4108_CR11","first-page":"543","volume":"21","author":"D Orentreich","year":"1995","unstructured":"Orentreich D, Orentreich N (1995) Subcutaneous incisionless (Subcision) surgery for the correction of depressed scars and wrinkles. Dermatol Surg 21:543\u2013549","journal-title":"Dermatol Surg"},{"key":"4108_CR12","doi-asserted-by":"crossref","unstructured":"IRIARTE, Christopher et al (2017) Review of applications of microneedling in dermatology. Clinical, cosmetic, and investigational dermatology, 289\u2013298","DOI":"10.2147\/CCID.S142450"},{"issue":"11","key":"4108_CR13","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00007611-197511000-00009","volume":"68","author":"OT Norwood","year":"1975","unstructured":"Norwood OT (1975) Male pattern baldness: classification and incidence. South Med J 68(11):1359\u20131365","journal-title":"South Med J"},{"key":"4108_CR14","doi-asserted-by":"crossref","unstructured":"Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP Alopecia areata. Nat Reviews Disease Primers 2017 Mar 16;3(1):1\u20137","DOI":"10.1038\/nrdp.2017.11"},{"key":"4108_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/0974-2077.53097","volume":"2","author":"S Murugusundram","year":"2009","unstructured":"Murugusundram S (2009) Serenoa Repens: does it have any role in the management of androgenetic alopecia?? J Cutan Aesthet Surg 2:31\u201332","journal-title":"J Cutan Aesthet Surg"},{"key":"4108_CR16","first-page":"309","volume":"29","author":"B Kreutzkamp","year":"2006","unstructured":"Kreutzkamp B (2006) Does saw palmetto extract work? Med Monatsschr Pharm 29:309\u2013310","journal-title":"Med Monatsschr Pharm"},{"key":"4108_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000475388","volume":"26","author":"G Strauch","year":"1994","unstructured":"Strauch G, Perles P, Vergult G et al (1994) Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the Inhibition of 5-alpha reductase in healthy male volunteers. Eur Urol 26:247\u2013252","journal-title":"Eur Urol"},{"key":"4108_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002409900098","volume":"28","author":"RM Levin","year":"2000","unstructured":"Levin RM, Das AK (2000) A scientific basis for the therapeutic effects of pygeum Africanum and Serenoa Repens. Urol Res 28:201\u2013209","journal-title":"Urol Res"},{"issue":"126","key":"4108_CR19","doi-asserted-by":"crossref","first-page":"126ra34","DOI":"10.1126\/scitranslmed.3003122","volume":"4","author":"LA Garza","year":"2012","unstructured":"Garza LA, Liu Y, Yang Z et al (2012) Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Sci Transl Med 4(126):126ra34","journal-title":"Sci Transl Med"},{"issue":"4","key":"4108_CR20","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/jocd.13940","volume":"20","author":"MS ZAKY","year":"2021","unstructured":"ZAKY MS et al (2021) Therapeutic implications of topical Cetirizine 1% in treatment of male androgenetic alopecia: A case-controlled study. J Cosmet Dermatol 20(4):1154\u20131159","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"4108_CR21","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/jocd.13727","volume":"20","author":"AS Salem","year":"2021","unstructured":"Salem AS, Ibrahim HS, Abdelaziz HH et al (2021) Implications of cigarette smoking on early-onset androgenetic alopecia: a cross-sectional study. J Cosmet Dermatol 20(4):1318\u20131312","journal-title":"J Cosmet Dermatol"},{"key":"4108_CR22","doi-asserted-by":"crossref","unstructured":"GALAL S, MAHMOUD W (2023) AHMED, Noha. Efficacy of Topical Cetirizine 1% in Treatment of Androgenic Alopecia: Clinical and Dermoscopic Evaluation","DOI":"10.21203\/rs.3.rs-3179366\/v1"},{"issue":"6","key":"4108_CR23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/PRS.0b013e31826d104f","volume":"130","author":"J Gatherwright","year":"2012","unstructured":"Gatherwright J, Liu MT, Gliniak C, Totonchi A, Guyuron B (2012) The contribution of endogenous and exogenous factors to female alopecia: a study of identical twins. Plast Reconstr Surg 130(6):1219\u20131226","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"4108_CR24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000074111","volume":"207","author":"RM Tr\u00fceb","year":"2003","unstructured":"Tr\u00fceb RM (2003) Is androgenetic alopecia a photoaggravated dermato-sis? Dermatology 207(4):343\u2013348","journal-title":"Dermatology"},{"issue":"2 suppl","key":"4108_CR25","first-page":"25","volume":"37","author":"R R\u00fceb","year":"2015","unstructured":"R\u00fceb R (2015) M.The impact of oxidative stress on hair.internationaljournal. Cosmet Sci 37(2):25\u201330","journal-title":"Cosmet Sci"},{"issue":"11","key":"4108_CR26","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1111\/jocd.15309","volume":"21","author":"X CHEN","year":"2022","unstructured":"CHEN X, XIANG H, YANG (2022) Ming. Topical Cetirizine for treating androgenetic alopecia: A systematic review. J Cosmet Dermatol 21(11):5519\u20135526","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"4108_CR27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/bjd.17354","volume":"180","author":"WC CRANWELL","year":"2019","unstructured":"CRANWELL WC, SINCLAIR R (2019) Sunscreen and facial skincare products in frontal fibrosing alopecia: a case\u2013control study. Br J Dermatol 180(4):943\u2013944","journal-title":"Br J Dermatol"},{"issue":"2","key":"4108_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/0974-7753.188033","volume":"8","author":"SIAHTWMUIR-GREENL SHAPIRO","year":"2016","unstructured":"SHAPIRO SIAHTWMUIR-GREENL (2016) Female pattern hair loss: a retrospective study in a tertiary referral center. Int J Trichology 8(2):57","journal-title":"Int J Trichology"},{"issue":"4","key":"4108_CR29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2006.01920.x","volume":"21","author":"VN SEHGAL","year":"2007","unstructured":"SEHGAL VN et al (2007) Male pattern androgenetic alopecia in an Indian context: a perspective study. J Eur Acad Dermatol Venereol 21(4):473\u2013479","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4108_CR30","first-page":"202","volume":"41","author":"PH Tang","year":"2000","unstructured":"Tang PH, Chia HP et al (2000) A community-based study of male androgenetic alopecia in Bishan, Singapore. Singap Med J 41:202\u2013205","journal-title":"Singap Med J"},{"key":"4108_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2133.2001.04289.x","volume":"145","author":"JH Paik","year":"2001","unstructured":"Paik JH, Yoon JB, Sim WY et al (2001) The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol 145:95\u201390","journal-title":"Br J Dermatol"},{"key":"4108_CR32","unstructured":"Olsen EA (2003) Disorders of hair growth: diagnosis and treatment. McGraw-Hill, Medical Pub. Division"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04108-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:17:27Z","timestamp":1743725847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04108-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4108"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04108-y","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the research ethical committee of Faculty of Medicine, Beni-Suef University with ethical approval number (FWBSU003172). The FM-BSU REC is organized and operated according to the declaration of Helsinki The purpose of the study was explained for each participant and a written informed consent was taken.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"665"}}